Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabetta Poluzzi

Showing results (71-80 of 189) with videos related to

Pageof 19
Sort By:
Parkinsonism & Related Disorders|August 16, 2021
Impulsive conditions in Parkinson's disease: A pharmacosurveillance-supported listMichele Fusaroli, Emanuel Raschi, Manuela Contin, et al.
Translational Psychiatry|January 24, 2025
The interface of depression and diabetes: treatment considerationsGiuseppe Fanelli, Emanuel Raschi, Gaye Hafez, et al.
International Journal of Cardiology|July 31, 2018
Drug-induced Kounis syndrome: A matter of pharmacovigilanceEmanuel Raschi, Lorenzo Fertonani Affini, Ippazio Cosimo Antonazzo, et al.
BMC Complementary and Alternative Medicine|July 25, 2014
Use of phytoestrogens and effects perceived by postmenopausal women: result of a questionnaire-based surveyAnna Girardi, Carlo Piccinni, Emanuel Raschi, et al.
European Journal of Clinical Pharmacology|August 2, 2013
Trend in SSRI-SNRI antidepressants prescription over a 6-year period and predictors of poor adherenceElisabetta Poluzzi, Carlo Piccinni, Elisa Sangiorgi, et al.
Drug Safety|August 12, 2023
Authors' Reply to Cappello et al. Comment on: "Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System"Michele Fusaroli, Guido Pelletti, Valentina Giunchi, et al.
Drug Safety|April 13, 2015
Drug-induced renal damage in preterm neonates: state of the art and methods for early detectionAnna Girardi, Emanuel Raschi, Silvia Galletti, et al.
Drug Safety|July 11, 2024
Adopting STOPP/START Criteria Version 3 in Clinical Practice: A Q&A Guide for Healthcare ProfessionalsCarlotta Lunghi, Marco Domenicali, Stefano Vertullo, et al.
The Oncologist|August 8, 2019
Serious Cutaneous Toxicities with Immune Checkpoint Inhibitors in the U.S. Food and Drug Administration Adverse Event Reporting SystemEmanuel Raschi, Ippazio Cosimo Antonazzo, Michelangelo La Placa, et al.
Expert Opinion on Biological Therapy|July 31, 2025
Treatment sequences in moderate-to-severe psoriasis: a hospital-based retrospective analysisAngela Boccia, Valentina Giunchi, Luca Girau, et al.
Pageof 19

Showing results (71-80 of 189) with videos related to

Sort By:
Pageof 19
Parkinsonism & Related Disorders|August 16, 2021
Impulsive conditions in Parkinson's disease: A pharmacosurveillance-supported listMichele Fusaroli, Emanuel Raschi, Manuela Contin, et al.
Translational Psychiatry|January 24, 2025
The interface of depression and diabetes: treatment considerationsGiuseppe Fanelli, Emanuel Raschi, Gaye Hafez, et al.
International Journal of Cardiology|July 31, 2018
Drug-induced Kounis syndrome: A matter of pharmacovigilanceEmanuel Raschi, Lorenzo Fertonani Affini, Ippazio Cosimo Antonazzo, et al.
BMC Complementary and Alternative Medicine|July 25, 2014
Use of phytoestrogens and effects perceived by postmenopausal women: result of a questionnaire-based surveyAnna Girardi, Carlo Piccinni, Emanuel Raschi, et al.
European Journal of Clinical Pharmacology|August 2, 2013
Trend in SSRI-SNRI antidepressants prescription over a 6-year period and predictors of poor adherenceElisabetta Poluzzi, Carlo Piccinni, Elisa Sangiorgi, et al.
Drug Safety|August 12, 2023
Authors' Reply to Cappello et al. Comment on: "Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System"Michele Fusaroli, Guido Pelletti, Valentina Giunchi, et al.
Drug Safety|April 13, 2015
Drug-induced renal damage in preterm neonates: state of the art and methods for early detectionAnna Girardi, Emanuel Raschi, Silvia Galletti, et al.
Drug Safety|July 11, 2024
Adopting STOPP/START Criteria Version 3 in Clinical Practice: A Q&A Guide for Healthcare ProfessionalsCarlotta Lunghi, Marco Domenicali, Stefano Vertullo, et al.
The Oncologist|August 8, 2019
Serious Cutaneous Toxicities with Immune Checkpoint Inhibitors in the U.S. Food and Drug Administration Adverse Event Reporting SystemEmanuel Raschi, Ippazio Cosimo Antonazzo, Michelangelo La Placa, et al.
Expert Opinion on Biological Therapy|July 31, 2025
Treatment sequences in moderate-to-severe psoriasis: a hospital-based retrospective analysisAngela Boccia, Valentina Giunchi, Luca Girau, et al.
Pageof 19